Julius Baer launching biotech fund in UK

clock

Swiss wealth manager Julius Baer is launching its Biotech fund to UK investors.

Launched on 31 January 2008, the Julius Baer Biotech fund's euro share class returned 4.75% in its first full year. The fund focuses on companies which develop products and technology for four sectors - healthcare, agricultural, food science and environmental. Managed by Eric Bernhardt and Nathalie Flury, the fund plays on the fact investment in biotech in the US - where this fund focus most of its portfolio - trebled between 1996 and 2008. Biotech beat the broader indices in 2008 - the S&P500 lost around 40% over the year, while the Nasdaq Biotechnology Index declined by 12%. Bernh...

To continue reading this article...

Join Professional Adviser

  • Unlimited access to real-time news, industry insights and market intelligence.
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters.
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection.
  • Members-only access to the editor’s weekly Friday commentary
  • 
 Be the first to hear about our events and awards programmes.

Join

 

Already a Professional Adviser member?

Login

More on Green

Industry raises concerns as regulator's SDR consultation closes

Industry raises concerns as regulator's SDR consultation closes

Three categories of investment labels to be used

Beth Brearley
clock 25 January 2023 • 3 min read
Bringing clarity: The importance of ESG investment labels

Bringing clarity: The importance of ESG investment labels

The FCA's consultation on the issue closes on 25 January

Jim Henning
clock 25 January 2023 • 4 min read
Meet the ESG Investment Influencers: James Penny of TAM Asset Management

Meet the ESG Investment Influencers: James Penny of TAM Asset Management

Latest in the series features TAM Asset Management CIO

Investment Week
clock 19 December 2022 • 1 min read